Agilent and Applied Proteomics Will Collaborate
Friday, March 08, 2013
Collaboration to maximize capabilities of highly multiplexed protein assays.
Big R&D Investment Trend as Mid-Cap Biotechs Push to Get Drugs to Market
Thursday, March 07, 2013
20% of overall increase in R&D expenditure in just a year.
Covance and M2Gen® Enter into Alliance
Friday, March 01, 2013
Combines Covance’s comprehensive drug development capabilities with M2Gen’s innovative cancer-focused data warehouse to help accelerate development of targeted therapies for cancer patients.
'Defective' Virus Plays Major Role in Spread of Disease
Friday, March 01, 2013
Defective viruses now appear able to play an important role in the spread of disease, new research by UCLA life scientists indicates.
Method Development to Estimate the Purity of Vesicle Preparations
Thursday, February 28, 2013
Nanoparticle tracking analysis is used to estimate the purity of vesicle preparations at the Cardiff University School of Medicine.
Genzyme Receives Company Award
Thursday, February 28, 2013
Genzyme, announced that it has received a Company Award from EURORDIS, the largest European patient organization in the field of rare diseases.
New Tool in the Fight against Tropical Diseases
Thursday, February 28, 2013
A novel tool exploits baker's yeast to expedite the development of new drugs to fight multiple tropical diseases.
Chemists Find Help from Nature in Fighting Cancer
Thursday, February 28, 2013
Study of several dozen compounds based on a fungal chemical shows potent anti-tumor activity.
Yeast Study Yields Potential for New Cholesterol, Anti-Fungal Drugs
Thursday, February 28, 2013
While studying a mutant strain of yeast, Purdue University researchers may have found a new target for drugs to combat cholesterol and fungal diseases.
|
|
|
|
|
|
